Screening the receptorome yields validated molecular targets for drug discovery
- PMID: 16712488
- DOI: 10.2174/138161206776873680
Screening the receptorome yields validated molecular targets for drug discovery
Abstract
With the recently completed sequencing and annotation of the human genome, it has become clear that a significant portion of the genome encodes signal-transducing molecules including receptors, protein kinases, ion channels, transporters and coupling proteins. This review focuses on membrane-localized receptors, which represent the largest single group of signal-transducing molecules. Indeed, one can estimate that nearly 10% of the human genome encodes membrane-localized receptors (e.g. G-protein coupled receptors, ligand-gated ion channels and transporters). We have defined that portion of the human genome that encodes 'receptors' the receptorome. In this article, we will demonstrate how the massively parallel screening of the receptorome provides a facile and under-utilized screening platform for drug discovery. Using case studies, we will show how receptorome-based screening elucidates the mechanisms responsible for serious side-effects of both approved and investigational medications. Additionally, we will provide evidence that receptorome-based screening provides insights into novel therapeutic indications of approved medications and serves to validate targets for therapeutic drug discovery.
Similar articles
-
Receptorome screening: a powerful, facile approach to better understand and engineer drugs.Drug News Perspect. 2009 Oct;22(8):459-66. Drug News Perspect. 2009. PMID: 20016855 Review.
-
Screening the receptorome: an efficient approach for drug discovery and target validation.Drug Discov Today. 2006 Aug;11(15-16):708-16. doi: 10.1016/j.drudis.2006.06.012. Drug Discov Today. 2006. PMID: 16846798 Review.
-
Receptor systems: will mining the receptorome yield novel targets for pharmacotherapy?Pharmacol Ther. 2005 Oct;108(1):59-64. doi: 10.1016/j.pharmthera.2005.06.013. Pharmacol Ther. 2005. PMID: 16083965 Review.
-
Screening the receptorome.J Psychopharmacol. 2006 Jul;20(4 Suppl):41-6. doi: 10.1177/1359786806066045. J Psychopharmacol. 2006. PMID: 16785269 Review.
-
Screening the receptorome to discover the molecular targets for plant-derived psychoactive compounds: a novel approach for CNS drug discovery.Pharmacol Ther. 2004 May;102(2):99-110. doi: 10.1016/j.pharmthera.2004.03.004. Pharmacol Ther. 2004. PMID: 15163592 Review.
Cited by
-
Systems chemical biology.Nat Chem Biol. 2007 Aug;3(8):447-50. doi: 10.1038/nchembio0807-447. Nat Chem Biol. 2007. PMID: 17637771 Free PMC article.
-
Identifying mechanism-of-action targets for drugs and probes.Proc Natl Acad Sci U S A. 2012 Jul 10;109(28):11178-83. doi: 10.1073/pnas.1204524109. Epub 2012 Jun 18. Proc Natl Acad Sci U S A. 2012. PMID: 22711801 Free PMC article.
-
Drug Repurposing Is a New Opportunity for Developing Drugs against Neuropsychiatric Disorders.Schizophr Res Treatment. 2016;2016:6378137. doi: 10.1155/2016/6378137. Epub 2016 Mar 17. Schizophr Res Treatment. 2016. PMID: 27073698 Free PMC article. Review.
-
Regulator of G-protein signaling 18 controls both platelet generation and function.PLoS One. 2014 Nov 18;9(11):e113215. doi: 10.1371/journal.pone.0113215. eCollection 2014. PLoS One. 2014. PMID: 25405900 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources